Value Propositions

  • Value-Based Drug Pricing a New Target for a Large PBM Company in Its Negotiations with Pharmaceutical Companies
  • Prenatal Blood Test Can Also Detect Cancer in Pregnant Women, Potentially in Other Populations
  • Myxoma, a Virus Found in Rabbits, Prevents GVHD in Bone Marrow Transplant While Destroying Cancer Cells
  • First-in-Class Inducer of the KLF4 Gene Receives FDA Designation as Orphan Drug
  • New Genetic Tests for Breast Cancer on the Horizon, May Challenge Current Screening Strategy
  • Turbo-Charging the Immune System Potential Game-Changer in Killing Cancer
  • New Immuno-oncology Collaboration to Promote CAR T-Cell Therapies
Granulomatosis with polyangiitis (GPA) is a rare disease characterized most often by inflammation of the small blood vessels of the respiratory system, although the kidneys and other organs may also be affected. GPA is complex, and prompt diagnosis and treatment are necessary to avoid serious complications.
The Office of the National Coordinator for Health IT was established in 2004 by executive action. In 2009, Congress authorized the Meaningful Use (MU) program, which offered financial incentives for adopting electronic health records (EHR) and other information technology (IT) tools.
In an earlier study, Tanaka and colleagues found that cost-effectiveness appears to favor tocilizumab (TCZ), a humanized anti-interleukin-6 receptor monoclonal antibody, in comparison with TNF inhibitors in patients with rheumatoid arthritis (RA).
Shih-Yin Chen, PhD, and her colleagues analyzed annual healthcare utilization and costs related to the use of glucocorticoid (GC) drugs among 5 cohorts of adult patients with systemic lupus erythematosus (SLE).
  • Genetic Mutations Rampant in Pancreatic Cancers: Targeted Drugs Hold Key to Therapy
  • Tetanus Booster Against Cytomegalovirus Enhances the Immune System, Improves Survival in Glioblastoma
  • Polygenic Risk Score for Breast Cancer on the Horizon
  • CLL Therapy Named “Cancer Advance of the Year” by ASCO
  • Novel Test Can Identify Apoptosis from Cancer Drugs in 16 Hours
  • Filgrastim-Sndz First Biosimilar Approved by the FDA
  • Type of Health Insurance Affects Clinical Outcomes in Patients with Brain Tumor
With data from the Humana commercial claims database, researchers evaluated the use and annual costs of biologic agents in the treatment of several autoimmune diseases.
The 2012 American College of Rheumatology Guidelines for Management of Gout recommends xanthine oxidase inhibitor therapy with allopurinol or febuxostat as urate-lowering therapy (ULT) in the treatment of gout. By design, the guidelines do not address cost-effectiveness.
Page 4 of 21
Results 31 - 40 of 206
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology